News
Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...
Aerospike is introducing Aerospike Graph Service (AGS) 2.5.0, supporting strong consistency (SC) in graph workloads to enable guaranteed atomicity and isolation for real-time graph updates.
Rather than seeing this as a setback, SurgeGraph views it as a foundation for something bigger. Zero to Hero will push forward with the same principles but with a renewed mission: proving that ...
Collibra, the leader in unified governance for data and AI, announced today that it has received the 2025 Google Cloud Data & Analytics Partner of the Year Award Governance.
This paper introduces GRACE, an end-to-end FPGA-based graph processing accelerator with a graph reordering engine and a Pull-based Vertex-Centric Programming Model (PL-VCPM) Engine. Firstly, GRACE ...
Securiti, the pioneer of the Data+AI Command Center, today announced its recognition as the highest-rated Data Security Posture Management (DSPM) solution by GigaOm. In the 2025 edition of the GigaOm ...
This is a Pytorch implementation of Gaussian Mixture Model Convolutional Networks (MoNet) for the tasks of image classification, vertex classification on generic graphs, and dense intrinsic shape ...
Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex ...
Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.
Vertex Minerals (ASX:VTX) is tuning its processing plant to cater for a wider range of feedstock at its Reward Gold mine in New South Wales.
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results